Novartis India informs about appointment of secretarial auditor

10 May 2025 Evaluate

Pursuant to Regulation 24(A) and Regulation 30 read with Para A of Part A of Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time), Novartis India has informed that the Board of Directors of the Company, at its meeting held on Friday, May 09, 2025, considered and approved the appointment of MK Saraf & Associates LLP, Practicing Company Secretary, (Firm Registration Number (FRN) : L2025MH018600) and (Peer Review Certificate No.6694/2025) as Secretarial Auditor of the Company with effect from April 1, 2025, for a period of 5 consecutive years up to March 31,2030 and to fix their remuneration as may be mutually agreed subject to the approval of the members at the ensuing Annual General Meeting (‘AGM’) of the Company. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 are given in 'Annexure A’ attached to this letter.

The above information is a part of company’s filings submitted to BSE.

Novartis Share Price

785.60 -1.65 (-0.21%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Redington 271.15
Adani Enterprises 2231.85
Amrapali Industries 14.81
Rashi Peripheral 357.00
PDS 366.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×